CRKN · As filed with the SEC
Crown Electrokinetics income statement, by fiscal year
The statement as Crown Electrokinetics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Operations and Comprehensive Loss · USD thousands, except per-share amounts
| USD thousands, except per-share amounts | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Mar 31, 2021 |
|---|---|---|---|---|
| Revenue | 19,701 | 153 | — | — |
| Cost of revenue | — | (886) | — | — |
| Depreciation and amortization | — | (733) | — | — |
| Nonrelated Party | 15,078 | — | — | — |
| Related Party | 5,337 | — | — | — |
| Gross margin | (714) | — | — | — |
| Operating expenses: | ||||
| Research and development | 3,367 | (2,231) | 4,107 | 3,539.86 |
| Selling, general and administrative | 20,045 | (14,962) | 11,001 | 15,812.37 |
| Goodwill impairment charge | — | (649) | — | — |
| Goodwill impairment charge | 0 | — | — | — |
| Total operating expenses | 23,412 | — | 15,108 | 19,352.22 |
| Loss from operations | (24,126) | (19,308) | (15,108) | (19,352.22) |
| Other income | — | — | — | 6.73 |
| Other expense | — | — | — | (55.44) |
| Other income (expense), net: | ||||
| Other expense | — | — | (74) | — |
| Interest expense | — | (9,417) | (7) | (3,196.26) |
| Loss on exchange of notes payable for common stock and warrants | — | — | — | (1,527.18) |
| Change in fair value of warrant liability | — | — | 1,023 | (2,360.54) |
| Interest expense | (994) | — | — | — |
| Loss on extinguishment of warrant liability | 0 | (504) | — | — |
| Loss on extinguishment of debt | 0 | (2,345) | — | (14,257.50) |
| Gain on issuance of convertible notes | 0 | 64 | — | — |
| Change in fair value of warrants | 0 | 10,458 | — | — |
| Change in fair value of notes | 0 | (7,040) | (149) | — |
| Change in fair value of derivative liability | — | 401 | — | (12.71) |
| Other expense | — | (1,293) | — | — |
| Change in fair value of derivative liability | 0 | — | — | — |
| Realized loss from ELOC derivative | (800) | — | — | — |
| Other expense, net | (26) | — | — | — |
| Total other expense, net | (1,820) | (9,676) | 793 | (21,402.90) |
| Loss before income taxes | — | (28,984) | — | — |
| Net loss and comprehensive loss | (25,946) | (28,984) | (14,315) | (40,755.13) |
| Net loss per share, basic and diluted: (in Dollars per share) | — | — | — | (4.60) |
| Weighted average shares outstanding, basic and diluted: (in Shares) | — | — | — | 8,851,151 |
| Deemed dividend | — | (6) | — | — |
| Cumulative dividends on Series D preferred stock | 0 | — | — | — |
| Preferred Stock Series A, B and C | (2,147) | — | — | — |
| Preferred Stock Series F, F-1, and F-2 | (3,874) | — | — | — |
| Cumulative dividends | — | — | (55) | — |
| Cumulative dividends on Series A preferred stock | (18) | (19) | — | — |
| Cumulative dividends on Series B preferred stock | (17) | (107) | — | — |
| Cumulative dividends on Series C preferred stock | (46) | (30) | — | — |
| Cumulative dividends on Series D preferred stock | 0 | (53) | — | — |
| Cumulative dividends on Series F preferred stock | — | (272) | — | — |
| Series F Preferred Stock | (341) | (110) | — | — |
| Cumulative dividends on Series F-2 preferred stock | — | (79) | — | — |
| Series F-1 Preferred Stock | (60) | — | — | — |
| Series F-2 Preferred Stock | (19) | — | — | — |
| Cumulative dividends on Series A preferred stock | (18) | — | — | — |
| Cumulative dividends on Series B preferred stock | (17) | 107 | — | — |
| Cumulative dividends on Series C preferred stock | (46) | 30 | — | — |
| Cumulative dividends on Series D preferred stock | — | 53 | — | — |
| Series F Preferred Stock | (341) | 272 | — | — |
| Series F-1 Preferred Stock | (60) | — | — | — |
| Series F-2 Preferred Stock | (19) | — | — | — |
| Net loss attributable to common stockholders | (32,468) | (29,660) | (14,370) | — |
| Net loss per share attributable to common stockholders (in Dollars per share) | — | — | (0.82) | — |
| Diluted (in dollars per share) | (548.26) | — | — | — |
| Net loss per share attributable to common stockholders (in dollars per share) | (548.26) | (5.46) | — | — |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | ||||
| Weighted average shares outstanding, basic (in shares) | 59,220 | 5,429,259 | 17,436,174 | — |
| Weighted average shares outstanding, diluted (in shares) | 59,220 | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.